CONMED CORPORATION Amortization of Debt Discount (Premium)
CONMED CORPORATION (CNMD) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2024-02-28
- CONMED CORPORATION amortization of debt discount (premium) for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION amortization of debt discount (premium) for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION amortization of debt discount (premium) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION amortization of debt discount (premium) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION amortization of debt discount (premium) for fiscal 2023 was $0.00.
- CONMED CORPORATION amortization of debt discount (premium) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CONMED CORPORATION amortization of debt discount (premium) for fiscal 2021 was $10.22M, a 5.42% increase from fiscal 2020.
- CONMED CORPORATION amortization of debt discount (premium) for fiscal 2020 was $9.69M, a 16.74% increase from fiscal 2019.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | $2.61M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | $2.61M derived: sum of 3 quarters · filed 2024-02-28 | $5.19M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $2.61M derived: sum of 2 quarters · filed 2024-02-28 | $5.19M derived: sum of 3 quarters · filed 2024-02-28 | $7.71M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.19M derived: sum of 2 quarters · filed 2024-02-28 | $7.71M derived: sum of 3 quarters · filed 2024-02-28 | $10.22M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $5.11M derived: sum of 2 quarters · filed 2022-10-27 | $7.61M 10-Q · filed 2022-10-27 | $10.06M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $5.03M 10-Q · filed 2022-07-28 | $7.48M derived: sum of 3 quarters · filed 2023-02-21 | $9.91M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $2.50M 10-Q · filed 2022-05-05 | $4.96M derived: sum of 2 quarters · filed 2023-02-21 | $7.38M derived: sum of 3 quarters · filed 2023-02-21 | $9.88M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.88M derived: sum of 2 quarters · filed 2023-02-21 | $7.38M derived: sum of 3 quarters · filed 2023-02-21 | $9.69M 10-K · filed 2023-02-21 |
| 2020-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $4.93M derived: sum of 2 quarters · filed 2021-10-28 | $7.24M 10-Q · filed 2021-10-28 | $9.46M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $2.50M 10-Q · filed 2020-07-30 | $4.81M 10-Q · filed 2021-07-29 | $7.03M derived: sum of 3 quarters · filed 2022-02-22 | $9.29M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $2.26M 10-Q · filed 2021-04-29 | $4.53M derived: sum of 2 quarters · filed 2022-02-22 | $6.79M derived: sum of 3 quarters · filed 2022-02-22 | $9.09M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.53M derived: sum of 2 quarters · filed 2022-02-22 | $6.83M derived: sum of 3 quarters · filed 2022-02-22 | $8.30M 10-K · filed 2022-02-22 |
| 2019-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $4.56M derived: sum of 2 quarters · filed 2020-10-29 | $6.04M 10-Q · filed 2020-10-29 | $6.07M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $2.30M 10-Q · filed 2020-07-30 | $3.77M 10-Q · filed 2020-07-30 | $3.81M derived: sum of 3 quarters · filed 2021-02-22 | $3.81M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.51M 10-Q · filed 2020-04-30 | $1.51M derived: sum of 2 quarters · filed 2021-02-22 | $1.51M derived: sum of 3 quarters · filed 2021-02-22 | $1.51M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-22 | $0.00 10-K · filed 2021-02-22 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-02-24 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $0.00 derived: sum of 2 quarters · filed 2014-02-24 | $0.00 derived: sum of 3 quarters · filed 2014-02-24 | $0.00 10-K · filed 2014-02-24 |
| 2012-09-30 | $0.00 10-Q · filed 2012-10-29 | $0.00 derived: sum of 2 quarters · filed 2012-10-29 | $0.00 10-Q · filed 2012-10-29 | $565.00K derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $0.00 10-Q · filed 2012-07-30 | $0.00 10-Q · filed 2012-07-30 | $565.00K derived: sum of 3 quarters · filed 2014-02-24 | $1.70M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-01 | $565.00K derived: sum of 2 quarters · filed 2014-02-24 | $1.70M derived: sum of 3 quarters · filed 2014-02-24 | $2.81M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $1.70M derived: sum of 2 quarters · filed 2014-02-24 | $2.81M derived: sum of 3 quarters · filed 2014-02-24 | $3.90M 10-K · filed 2014-02-24 |
| 2011-09-30 | $1.13M 10-Q · filed 2012-10-29 | $2.24M derived: sum of 2 quarters · filed 2012-10-29 | $3.34M 10-Q · filed 2012-10-29 | $4.42M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $1.11M 10-Q · filed 2012-07-30 | $2.21M 10-Q · filed 2012-07-30 | $3.28M derived: sum of 3 quarters · filed 2013-02-25 | $4.34M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $1.09M 10-Q · filed 2012-05-01 | $2.17M derived: sum of 2 quarters · filed 2013-02-25 | $3.23M derived: sum of 3 quarters · filed 2013-02-25 | $4.29M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $2.14M derived: sum of 2 quarters · filed 2013-02-25 | $3.19M derived: sum of 3 quarters · filed 2013-02-25 | $4.24M 10-K · filed 2013-02-25 |
| 2010-09-30 | $1.06M 10-Q · filed 2011-11-01 | $2.12M derived: sum of 2 quarters · filed 2011-11-01 | $3.17M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $1.06M 10-Q · filed 2011-08-09 | $2.11M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $4.11M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |